The global oral antibiotics market size was valued at USD 18.96 Billion in 2025, driven by the rising incidence of infectious diseases across the globe. The market is expected to grow at a CAGR of 2.50% during the forecast period of 2026-2035, with the values likely to rise USD 24.27 Billion by 2035.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
2.5%
Value in USD Billion
2026-2035
*this image is indicative*
Oral antibiotics refer to medical drugs such as tablets and capsules that are administered orally and are used to treat mild to moderate infections in the body. They eliminate the risk of canula-related infections to enhance the cost-effectiveness while effectively treating infectious diseases. Moreover, oral antibiotics are typically used to kill microbes in the body.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
With the rising incidence of chronic diseases like influenza and tuberculosis, the oral antibiotics market demand has grown in the historical period. The growing prevalence of urinary tract infections (UTIs), especially in women, has significantly boosted the demand for oral antibiotics such as Fosfomycin and ceftriaxone, among others.
With the sudden COVID-19 outbreak, the approvals for oral antibiotics by government bodies have seen an upswing. This can be attributed to enhance the treatment options for infectious diseases. In September 2023, the FDA granted its approval for Canada based Appili Therapeutics' liquid form of antibiotic drug called metronidazole. This liquid oral form is an effective alternative for those who are unable to administer antibiotics through injections or pills.
The oral antibiotics market growth is further driven by a profound emphasis on battling antibiotic resistance. A global non-profit organization CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) has awarded the researchers from the University of Melbourne with a whopping USD 1.75 million to develop an oral therapeutic that can restore the activity of antibiotics used to treat pneumonia. Such investments are expected to foster innovation and bring effective treatment alternatives for patients across the globe.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The EMR’s report titled “Oral Antibiotics Market Report and Forecast 2026-2035" offers a detailed analysis of the market based on the following segments:
Market Breakup by Class
Market Breakup by Spectrum of Antibiotics
Market Breakup by Applications
Market Breakup by Distribution Channel
Market Breakup by Region
The North America, particularly the United States, has dominated the oral antibiotics market share in the historical period. The market share can be accredited to the increasing number of drug approvals by the government bodies like the FDA. Furthermore, the region is experiencing several mergers and acquisitions wherein the healthcare giants are acquiring smaller companies to foster innovation and growth.
The Asia Pacific region is anticipated to experience a surge in the oral therapeutics market value, aided by improving research and healthcare infrastructure. In addition, the rising privatization in countries like India is driving the market forward with rapid adoption of latest technologies. There is immense focus on combating antibiotic resistance, with new seminars being arranged to educate the scientific community.
Europe, with a robust research infrastructure, is another centre of innovation for the oral antibiotics market. It is a huge market for oral antibiotic consumption, with a substantial amount of geriatric population, that is more prone to chronic diseases. The presence of several academic institutions and prominent pharmaceutical companies plays a major role in contributing to the significant market size.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 18.96 Billion in 2025, driven by the rising prevalence of infectious diseases across the globe.
The market is anticipated to grow at a CAGR of 2.50% during the forecast period of 2026-2035, likely to reach a market value of USD 24.27 Billion by 2035.
The market demand is fuelled by the growing focus on global health threats like COVID-19, the rising attempts to develop new antibiotics, and the increasing investment in research and development (R&D) activities of oral antibiotics.
The increased approvals for the application of new oral antibiotics is among the recent market trends. In September 2023, Canada based Appili Therapeutics' liquid form of antibiotic drug called metronidazole gained the FDA approval.
Penicillin’s, cephalosporins, macrolides, fluoroquinolones, tetracyclines, sulfonamides and trimethoprim, among others are the common drug classes.
It includes broad spectrum antibiotics as well as mid and narrow spectrum antibiotics.
Common application areas include respiratory infections, urinary tract infections (UTIs), skin infections, gastrointestinal infections, and sexually transmitted infections (STIs), among others.
Major distribution channels include hospital pharmacies, retail pharmacies and drug stores, and online pharmacies, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are Pfizer Inc., Novartis AG, GlaxoSmithKline plc (GSK), Merck & Co., Inc., AstraZeneca plc., Roche Holding AG, Bayer AG, Johnson & Johnson, Sanofi, Alkem Laboratories Ltd., Cipla Ltd., Lupin, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Abbott Laboratories.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Class |
|
| Breakup by Spectrum of Antibiotics |
|
| Breakup by Applications |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share